Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Prosion GmbH (Prosion Therapeutics)

PROSION Therapeutics is a drug development company with a proprietary platform that addresses highly unmet medical needs by unlocking undruggables. Starting off in oncology, PROSION Therapeutics mission is to develop new drugs against hard-to-treat diseases with the vision to directly benefit patients' survival and overall quality of life. As of 2022, PROSION Therapeutics is backed by the European Commission through their prestigious EIC Accelerator. *


Period Start 2020-09-02 established (s-off)
  Predecessor University of Cologne (Universität zu Köln)
Product Industry BIOTECH
Persons Person Chiha, Slim (Prosion 202308 Managing Director (CEO) + Co-Founder)
  Person 2 Yönel, Mutlu (Prosion 202308 Managing Director (CFO) + Co-Founder)
Region Region Köln (Cologne)
  Country Germany
  Street 53 Luxemburger Str.
  City 50674 Köln
  Tel +49-1578-8517161
    Address record changed: 2023-08-31
Basic data Employees n. a.
    * Document for »About Section«: Collaborative Drug Discovery, Inc.. (2/23/23). "Press Release: German Drug Development Company Prosion Therapeutics Selects CDD Vault to Host Its R&D Data". Cologne & San Francisco, CA.
Record changed: 2023-12-30


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Prosion GmbH (Prosion Therapeutics)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top